Literature DB >> 18797626

Access to medicines versus access to treatment: the case of type 1 diabetes.

David Beran1, Ariane McCabe, John S Yudkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18797626      PMCID： PMC2649458          DOI： 10.2471/blt.07.048710

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  5 in total

1.  The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.

Authors:  Shanti Mendis; Keiko Fukino; Alexandra Cameron; Richard Laing; Anthonio Filipe; Oussama Khatib; Jerzy Leowski; Margaret Ewen
Journal:  Bull World Health Organ       Date:  2007-04       Impact factor: 9.408

2.  Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-10       Impact factor: 79.321

3.  Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia.

Authors:  David Beran; John S Yudkin; Maximilian de Courten
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

Review 4.  Diabetes care in sub-Saharan Africa.

Authors:  David Beran; John S Yudkin
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

5.  Assessing health systems for type 1 diabetes in sub-Saharan Africa: developing a 'Rapid Assessment Protocol for Insulin Access'.

Authors:  David Beran; John S Yudkin; Maximilian de Courten
Journal:  BMC Health Serv Res       Date:  2006-02-24       Impact factor: 2.655
  5 in total
  9 in total

1.  Patent and exclusivity status of essential medicines for non-communicable disease.

Authors:  Tim K Mackey; Bryan A Liang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

2.  Systems medicine and integrated care to combat chronic noncommunicable diseases.

Authors:  Jean Bousquet; Josep M Anto; Peter J Sterk; Ian M Adcock; Kian Fan Chung; Josep Roca; Alvar Agusti; Chris Brightling; Anne Cambon-Thomsen; Alfredo Cesario; Sonia Abdelhak; Stylianos E Antonarakis; Antoine Avignon; Andrea Ballabio; Eugenio Baraldi; Alexander Baranov; Thomas Bieber; Joël Bockaert; Samir Brahmachari; Christian Brambilla; Jacques Bringer; Michel Dauzat; Ingemar Ernberg; Leonardo Fabbri; Philippe Froguel; David Galas; Takashi Gojobori; Peter Hunter; Christian Jorgensen; Francine Kauffmann; Philippe Kourilsky; Marek L Kowalski; Doron Lancet; Claude Le Pen; Jacques Mallet; Bongani Mayosi; Jacques Mercier; Andres Metspalu; Joseph H Nadeau; Grégory Ninot; Denis Noble; Mehmet Oztürk; Susanna Palkonen; Christian Préfaut; Klaus Rabe; Eric Renard; Richard G Roberts; Boleslav Samolinski; Holger J Schünemann; Hans-Uwe Simon; Marcelo Bento Soares; Giulio Superti-Furga; Jesper Tegner; Sergio Verjovski-Almeida; Peter Wellstead; Olaf Wolkenhauer; Emiel Wouters; Rudi Balling; Anthony J Brookes; Dominique Charron; Christophe Pison; Zhu Chen; Leroy Hood; Charles Auffray
Journal:  Genome Med       Date:  2011-07-06       Impact factor: 11.117

3.  Health systems research for policy change: lessons from the implementation of rapid assessment protocols for diabetes in low- and middle-income settings.

Authors:  David Beran; J Jaime Miranda; Maria Kathia Cardenas; Maryam Bigdeli
Journal:  Health Res Policy Syst       Date:  2015-10-01

4.  Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines lists.

Authors:  Yaser T Bazargani; Anthonius de Boer; Hubert G M Leufkens; Aukje K Mantel-Teeuwisse
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

5.  Low utilisation of diabetes medicines in Iran, despite their affordability (2000-2012): a time-series and benchmarking study.

Authors:  Amir Sarayani; Arash Rashidian; Kheirollah Gholami
Journal:  BMJ Open       Date:  2014-10-16       Impact factor: 2.692

Review 6.  Mitigating The Burden Of Diabetes In Sub-Saharan Africa Through An Integrated Diagonal Health Systems Approach.

Authors:  Tim Mercer; Alice C Chang; Lydia Fischer; Adrian Gardner; Immaculate Kerubo; Dan N Tran; Jeremiah Laktabai; Sonak Pastakia
Journal:  Diabetes Metab Syndr Obes       Date:  2019-10-31       Impact factor: 3.168

Review 7.  Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review.

Authors:  Carla Castillo-Laborde; Macarena Hirmas-Adauy; Isabel Matute; Anita Jasmen; Oscar Urrejola; Xaviera Molina; Camila Awad; Catalina Frey-Moreno; Sofia Pumarino-Lira; Fernando Descalzi-Rojas; Tomás José Ruiz; Barbara Plass
Journal:  Public Health Rev       Date:  2022-09-02

Review 8.  Access to medicines from a health system perspective.

Authors:  Maryam Bigdeli; Bart Jacobs; Goran Tomson; Richard Laing; Abdul Ghaffar; Bruno Dujardin; Wim Van Damme
Journal:  Health Policy Plan       Date:  2012-11-22       Impact factor: 3.344

9.  Managing non-communicable diseases at health district level in Cambodia: a systems analysis and suggestions for improvement.

Authors:  Bart Jacobs; Peter Hill; Maryam Bigdeli; Cheanrithy Men
Journal:  BMC Health Serv Res       Date:  2016-01-27       Impact factor: 2.655
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.